Cargando…

The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease

Mostrar otras versiones (1)

Lysosomal storage diseases (LSDs) are inherited disorders caused by lysosomal deficiencies and characterized by dysfunction of the autophagy-lysosomal pathway (ALP) often associated with neurodegeneration. No cure is currently available to treat neuropathology in LSDs. By studying a mouse model of m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monaco, Antonio, Maffia, Veronica, Sorrentino, Nicolina Cristina, Sambri, Irene, Ezhova, Yulia, Giuliano, Teresa, Cacace, Vincenzo, Nusco, Edoardo, De Risi, Maria, De Leonibus, Elvira, Schrader, Thomas, Klärner, Frank-Gerrit, Bitan, Gal, Fraldi, Alessandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132627/ https://www.ncbi.nlm.nih.gov/pubmed/32087148 http://dx.doi.org/10.1016/j.ymthe.2020.02.005

Ejemplares similares

The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease
por: Monaco, Antonio, et al.
Publicado: (2022)

Amyloid β-Protein Assembly: The Effect of Molecular Tweezers CLR01 and CLR03
por: Zheng, Xueyun, et al.
Publicado: (2015)

Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases
por: Sambri, Irene, et al.
Publicado: (2016)

Safety and pharmacological characterization of the molecular tweezer CLR01 – a broad-spectrum inhibitor of amyloid proteins’ toxicity
por: Attar, Aida, et al.
Publicado: (2014)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2020)

A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA
por: Sorrentino, Nicolina Cristina, et al.
Publicado: (2013)

The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

Enhancing the Therapeutic Potential of Sulfamidase for the Treatment of Mucopolysaccharidosis IIIA
por: Sorrentino, Nicolina Cristina, et al.
Publicado: (2019)

Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
por: Di, Jing, et al.
Publicado: (2021)

The molecular tweezer CLR01 inhibits Ebola and Zika virus infection
por: Röcker, Annika E., et al.
Publicado: (2018)

Retinal Degeneration in MPS-IIIA Mouse Model
por: Intartaglia, Daniela, et al.
Publicado: (2020)

Lysine-selective molecular tweezers are cell penetrant and concentrate in lysosomes
por: Li, Zizheng, et al.
Publicado: (2021)

The Molecular Tweezer CLR01 Stabilizes a Disordered Protein–Protein Interface
por: Bier, David, et al.
Publicado: (2017)

The Molecular Tweezer CLR01 Inhibits Antibody-Resistant Cell-to-Cell Spread of Human Cytomegalovirus
por: Brenner, Sina, et al.
Publicado: (2021)

Protein Aggregation and Dysfunction of Autophagy-Lysosomal Pathway: A Vicious Cycle in Lysosomal Storage Diseases
por: Monaco, Antonio, et al.
Publicado: (2020)

Molecular Lysine Tweezers Counteract Aberrant Protein Aggregation
por: Hadrovic, Inesa, et al.
Publicado: (2019)

Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases
por: de Pablo-Latorre, Raquel, et al.
Publicado: (2012)

Low-dose Gene Therapy Reduces the Frequency of Enzyme Replacement Therapy in a Mouse Model of Lysosomal Storage Disease
por: Alliegro, Marialuisa, et al.
Publicado: (2016)

Inhibition of Mutant αB Crystallin‐Induced Protein Aggregation by a Molecular Tweezer
por: Xu, Na, et al.
Publicado: (2017)

CLR via C#
por: Richter, Jeffrey
Publicado: (2010)

CLR via C#
por: Richter, Jeffrey
Publicado: (2012)

CLR via C♯
por: Richter, Jeffrey
Publicado: (2006)

Transcriptomic insights into the roles of the transcription factors Clr1, Clr2 and Clr4 in lignocellulose degradation of the thermophilic fungal platform Thermothelomyces thermophilus
por: Siebecker, Benedikt, et al.
Publicado: (2023)

polishCLR: A Nextflow Workflow for Polishing PacBio CLR Genome Assemblies
por: Chang, Jennifer, et al.
Publicado: (2023)

C.L.R. James : a life /
por: Dhondy, Farrukh
Publicado: (2001)

C.L.R. James : a critical introduction /
por: Nielsen, Aldon Lynn
Publicado: (1997)

The roles of the zinc finger transcription factors XlnR, ClrA and ClrB in the breakdown of lignocellulose by Aspergillus niger
por: Raulo, Roxane, et al.
Publicado: (2016)

Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches
por: Fraldi, Alessandro, et al.
Publicado: (2018)

Direct Target Network of the Neurospora crassa Plant Cell Wall Deconstruction Regulators CLR-1, CLR-2, and XLR-1
por: Craig, James P., et al.
Publicado: (2015)

Exploring the Binding Mechanism of a Supramolecular Tweezer CLR01 to 14-3-3σ Protein via Well-Tempered Metadynamics
por: Zhou, Xin, et al.
Publicado: (2022)

Molecular Tweezers Targeting Transthyretin Amyloidosis
por: Ferreira, Nelson, et al.
Publicado: (2014)

Genetic Variants of RAMP2 and CLR are Associated with Stroke
por: Koyama, Teruhide, et al.
Publicado: (2017)

Development of chimeric and bifunctional antagonists for CLR/RAMP receptors
por: Chang, Chia Lin, et al.
Publicado: (2019)

Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders
por: De Risi, Maria, et al.
Publicado: (2021)

Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
por: Tunold, Jon-Anders, et al.
Publicado: (2023)

Clr-f expression regulates kidney immune and metabolic homeostasis
por: Zein, Haggag S., et al.
Publicado: (2022)

Sustained Activation of CLR/RAMP Receptors by Gel-Forming Agonists
por: Chang, Chia Lin, et al.
Publicado: (2022)

C-Type Lectin Receptor (CLR)–Fc Fusion Proteins As Tools to Screen for Novel CLR/Bacteria Interactions: An Exemplary Study on Preselected Campylobacter jejuni Isolates
por: Mayer, Sabine, et al.
Publicado: (2018)

EPCT-09. CLR 131 IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC MALIGNANCIES
por: Puccetti, Diane, et al.
Publicado: (2020)

Vector and Host C-Type Lectin Receptor (CLR)–Fc Fusion Proteins as a Cross-Species Comparative Approach to Screen for CLR–Rift Valley Fever Virus Interactions
por: Schön, Kathleen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sggnbidjuf55hqd2ifnvhmello